Patent Yard Sign in
Canadian application, no grantCanada

Methods for cloning mammals using remodeling factors

CA 2450652 A1 · Owner: Forsberg, Erik J. · Inventors: Eilertsen, Kenneth; Forsberg, Erik J.; Betthauser, Jeffrey M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Methods and compositions are provided for remodeling nuclear donor material used in nuclear transfer procedures. By exposing donor chromatin to one or more exogenous remodeling factors, the limited ability of mammalian oocytes to remodel the chromatin of differentiated cells including fetal and live-born , somatic cells can be increased, resulting in dramatically improved cloning efficiencies.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 14, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 14, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 14, 2002
GrantedNo grant recorded
Term endedJune 14, 2022
Patent numberCA 2450652 A1
Classification (IPC)C12N15/87 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJune 14, 2002Term endedJune 14, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.